Vident Advisory LLC Reduces Position in CME Group Inc. $CME

Key Points

• Vident Advisory LLC reduced its stake in CME Group Inc. by 31.9% in Q1, owning 11,632 shares after selling 5,440 shares during the period.
• CME Group reported a $2.96 EPS for the last quarter, exceeding the consensus estimate of $2.91, with a quarterly revenue of $1.69 billion.
• The company announced a quarterly dividend of $1.25 per share, resulting in a yield of 1.9%, to be paid on September 25th.

Vident Advisory LLC reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 31.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,632 shares of the financial services provider's stock after selling 5,440 shares during the quarter. Vident Advisory LLC's holdings in CME Group were worth $3,087,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Wayfinding Financial LLC bought a new stake in CME Group in the first quarter worth about $25,000. Cornerstone Planning Group LLC lifted its stake in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management bought a new stake in CME Group during the 1st quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. bought a new stake in CME Group during the 1st quarter valued at about $32,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. UBS Group reiterated a "neutral" rating and set a $305.00 price objective on shares of CME Group in a report on Thursday, July 24th. Citigroup lifted their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Piper Sandler lifted their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Finally, Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $261.93.

Insider Buying and Selling

In other news, Director William R. Shepard acquired 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at $69,849,763.88. The trade was a 0.10% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Down 0.7%

Shares of NASDAQ:CME traded down $1.92 during trading hours on Thursday, hitting $267.43. The company's stock had a trading volume of 1,867,377 shares, compared to its average volume of 2,315,570. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $96.38 billion, a price-to-earnings ratio of 25.89, a P/E/G ratio of 4.82 and a beta of 0.43. The firm's fifty day moving average price is $275.32 and its 200 day moving average price is $269.61.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.56 EPS. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's payout ratio is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.